Vaxcyte, Inc. - Director's Dealing 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Vaxcyte, Inc. (PCVX)
CIK: 0001649094
Period of Report: 2025-09-02

Reporting Person: PICKERING GRANT (Director, CHIEF EXECUTIVE OFFICER)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-09-02	Common Stock	F	2857	$31.56	Disposed	516247	Direct
2025-09-02	Common Stock	F	4563	$31.56	Disposed	511684	Direct
2025-09-02	Common Stock	F	3420	$31.56	Disposed	508264	Direct

Security	Shares	Ownership
Common Stock	136215	Indirect
Common Stock	136215	Indirect

F1: Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs.

F2: Includes 329 shares acquired under the Issuer's Employee Stock Purchase Plan on May 16, 2025.

F3: Shares are held directly by a trust for the benefit of the Reporting Person's son.

F4: Shares are held directly by a trust for the benefit of the Reporting Person's daughter.